Vidwan-ID : 348658



  • Dr Bhumika Patel

  • Assistant Professor (Grade-III)
  • Institute of Pharmacy, Nirma University
Publications 2010 - 2024

Publications

  • 18
    Journal Articles
  • 6
    Review
  • 1
    Short Survey
  • 8
    Projects

Citations / H-Index

406 Citations
10 h-index
2 Citations

Altmetrics

4
4
11
158
4

Google Scholar

Co-author Network


Expertise

Medicinal Chemistry

Molecular modelling and Computer Aided Drug Design Techniques like QSAR, Pharmacophore modeling, Molecular docking, virtual screening, homology modeling, MD simulation, in-silico drug repurposing etc., Design and Synthesis of Potential Lead molecules, In-vitro screening of lead molecules as anti-cancer agents Wnt signaling, PARP Inhibitors, Porcupine Inhibitors

Personal Information

Dr Bhumika Patel

Female
Department of Pharmaceutical Chemistry NIRMA UNIVERSITY, Sarkhej - Gandhinagar Highway, Gota, Ahmedabad, Gujarat, India
, Gujarat, India - 382481


Experience

  • Assistant Professor (Grade-III)

    Department of Pharmacy

    Institute of Pharmacy, Nirma University


Qualification

  • PhD

    Nirma University, Ahmedabad


Honours and Awards

2019

Best Assistant Professor for Overall Category

Nirma University

2019

Full Travel Grant to Attend and Present Paper at ACS Conference

SERB, DST, Gov. of India

2019

Best Assistant Professor for Overall Category

Nirma University

2019

Full Travel Grant to Attend and Present Paper at ACS Conference

SERB, DST, Gov. of India

Read Less

Membership In Professional Bodies

2023

American Chemical Society

Annual Membership

2013

Indian Society of Chemist and Biologist

Life Member

2023

American Chemical Society

Annual Membership

2013

Indian Society of Chemist and Biologist

Life Member

Read Less

Membership In Committees

2020

UG Research Council, Institute of Pharmacy, Nirma University

Cordinator

2020

UG Research Council, Institute of Pharmacy, Nirma University

Cordinator

Read Less

Research Projects

Hit to Lead Optimization of NCEs as Selective Poly (ADP-ribose) Polymerase1 (PARP1) Inhibitors for the Treatment of Breast Cancer

Funding Agency : GSBTM

Biomarker based analytical profiling and grading of selected medicinal plants

Funding Agency : Nirma University

Exploring Heterocyclic Scaffolds as Telomerase Inhibitors for the Treatment of Cancer

Funding Agency : Nirma University

Read More

Hit to Lead Optimization of NCEs as Selective Poly (ADP-ribose) Polymerase1 (PARP1) Inhibitors for the Treatment of Breast Cancer

Funding Agency : GSBTM

Biomarker based analytical profiling and grading of selected medicinal plants

Funding Agency : Nirma University

Exploring Heterocyclic Scaffolds as Telomerase Inhibitors for the Treatment of Cancer

Funding Agency : Nirma University

Identification of Tetrahydroquinoline (THQ) derivatives as novel mTOR inhibitor with highly improved anticancer activity

Funding Agency : Nirma University

Design and Synthesis of Poly(ADP-ribose) Polymerase1 (PARP1) Inhibitors for the treatment of Cancer

Funding Agency : Nirma University

Solubility Enhancement of Lead candidates as Anti-diabetic Agents

Funding Agency : Nirma University

In-silico designing, synthesis and pharmacological screening of dipeptidyl peptidase- IV (DPP-IV) inhibitors as novel antidiabetic molecules

Funding Agency : GUJCOST

Design, synthesis and Phamacological evaluation of novel heterocyclic derivatives as anti-diabetic agents

Funding Agency : Nirma University

Read Less